Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Condition: Cataract Interventions: Drug: Clobetasol Propionate; Drug: Vehicle Sponsor: Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2020 Category: Research Source Type: clinical trials
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Condition: Cataract Interventions: Drug: Clobetasol propionate; Drug: Vehicle Sponsor: Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Intervention: Drug: Clobetasol propionate 0.05% Topical Oil Sponsor: Hill Dermaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials
Intradermal LPS and Antibiotics
Condition: Inflammation; Skin Interventions: Drug: Erythromycin 4% topical gel formulation:; Drug: Clindamycin 1% lotion formulation:; Drug: Prednisolone tablet (0.5mg/kg; parallel comparison):; Drug: Clobetasol propionate 0.05% topical formulation (crossover comparison):; Other: Lipopolysaccharide Sponsors: Centre for Human Drug Research, Netherlands; Cutanea Life Sciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2018 Category: Research Source Type: clinical trials
Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis
Condition: Psoriasis Intervention: Combination Product: Apremilast and Clobetasol Sponsor: Washington Dermatology Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2018 Category: Research Source Type: clinical trials
